Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126132001	12613200	1	I	20160719	20160724	20160802	20160802	EXP		BR-ALEXION PHARMACEUTICALS INC-A201605607	ALEXION		3.64	YR		M	Y	0.00000		20160802		CN	BR	BR

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126132001	12613200	1	PS	SOLIRIS	ECULIZUMAB	1	Intravenous (not otherwise specified)	600 MG, UNK							125166	600	MG	CONCENTRATE FOR SOLUTION FOR INFUSION
126132001	12613200	2	SS	SOLIRIS	ECULIZUMAB	1	Intravenous (not otherwise specified)	300 MG, UNK							125166	300	MG	CONCENTRATE FOR SOLUTION FOR INFUSION

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126132001	12613200	1	Haemolytic uraemic syndrome

Outcome of event

Reactions reported

Event ID	CASEID	DRUG REC ACT	PT
126132001	12613200		Cardio-respiratory arrest
126132001	12613200		Hypertension

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
126132001	12613200	1	20160219	20160219	0
126132001	12613200	2	20160226		0